Aptus Pharma (BOM:544529) Inventories, Raw Materials & Components: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544529 Aptus Pharma Ltd BOM:544529
18 GF Score
Price ₹269.50
! 6 Warning Signs
View Full Analysis

What is Aptus Pharma Inventories, Raw Materials & Components?

Aptus Pharma BOM:544529 +3.63% 18 Inventories, Raw Materials & Components is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Aptus Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Aptus Pharma Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Aptus Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptus Pharma Inventories, Raw Materials & Components Chart

Aptus Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00

Aptus Pharma Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BOM:544529
18GF Score
Aptus Pharma Ltd BOM:544529
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptus Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0.0 Mil mean?
Aptus Pharma (BOM:544529) has a Inventories, Raw Materials & Components of ₹0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Aptus Pharma and its competitors.
Is Aptus Pharma's Inventories, Raw Materials & Components too high?
Aptus Pharma's current Inventories, Raw Materials & Components is ₹0.0 Mil. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Inventories, Raw Materials & Components compare to MCK and COR?
Aptus Pharma's Inventories, Raw Materials & Components of ₹0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Aptus Pharma and its competitors. Aptus Pharma's current Inventories, Raw Materials & Components is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Inventories, Raw Materials & Components of ₹0.0 Mil. The current Inventories, Raw Materials & Components is ₹0.0 Mil. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Inventories, Raw Materials & Components is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptus Pharma Business Description

Address Narayan Nagar, Kalawad Road, SHREE Building, 1st Floor, Opp Satyasai Heart Hospital, Sau Uni Area, Rajkot, GJ, IND, 360005
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score

Get the complete analysis for BOM:544529

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹269.50
Price